China COVID-19 diagnostics market is estimated to see a decline in CAGR of 25.1% during the forecast period. China has significant market share in the global COVID-19 diagnostic market owing to the growing number of diagnostic screening in the country coupled with government initiatives for providing rapid screening for COVID-19. For instance, on May 22, 2020, Chinese health authorities in the city of Wuhan claimed that they have tested around 9.8 million people for COVID-19 within 10 days. The government of the Wuhan spent around $126.6 million on this campaign. In the pool testing campaign, the authorities set up at least 231 testing booths in neighborhoods across the city. Moreover, The Chinese National Health Committee’s data, which is compiled by the Chinese government confirms, as of June 22, 2020, China had conducted 90.41 million tests across the country.
China COVID-19 diagnostics market is segmented on the basis of technology type, end-use, sample type, and product type. By end-use, the COVID-19 diagnostic market is divided into laboratories, hospitals, diagnostic centers & clinics, and research institutes. By product type, the market is further segmented into instruments, reagents & kits, and laboratory testing services. By Sample type, the market is divided into oropharyngeal & nasopharyngeal swabs, blood, urine, saliva, and others. By technology type, the market is further segmented into PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test. Among these, the PCR segment has a major share in the COVID-19 diagnostics market. The factor that enhances the PCR test adoption includes a wide availability of tests and generation of the accurate results. However, due to its time consuming and expensive nature, these tests are substituted with other tests such as serology tests.
To Request a Sample of our Report on China COVID-19 Diagnostics Market: https://www.omrglobal.com/request-sample/china-covid-19-diagnostics-market
China COVID-19 Diagnostics Market Segmentation
By Type
- Instruments
- Reagents & Kits
- Laboratory Testing Services
By Technology Type
- PCR Test
- Antigen Test
- Chromatographic Immunoassay
- Fluorescent Immunoassay
- Chemiluminescent Immunoassay
- Serology Test
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Neutralization
- Chemiluminescent Immunoassay
- Rapid/ PoC Test
By Sample Type
- Oropharyngeal & Nasopharyngeal Swabs
- Blood
- Urine
- Saliva
- Others (Sperm)
By End-Users
- Laboratories
- Hospitals
- Diagnostic Centers & Clinics
- Research Institutes
A full Report of UK Chemical Market is Available @ https://www.omrglobal.com/industry-reports/china-covid-19-diagnostics-market
Company Profiles
- Anbio (Xiamen) Biotechnology Co., Ltd.
- Beijing Applied Biological Technologies Co., Ltd.
- BGI Group
- Chengdu CapitalBio Biotechnology Co., Ltd.
- Da An Gene Co., Ltd.
- Guangzhou Wondfo Biotech Co., Ltd.
- Maccura Biotechnology Co., Ltd.
- Sansure Biotech, Inc.
- Shanghai BioGerm Medical Biotechnology Co., Ltd
- Ustar Biotechnologies (Hangzhou), Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
